GL1X · GenesisL1 explorer

MolNFT v1 · #159002 · protein

The BETA2 adrenergic receptor bound to a negative allosteric modulator

6OBA · Beta-2 adrenergic RECEPTOR,LYSOZYME,BETA-2 adrenergic…: “The BETA2 adrenergic receptor bound to a negative allosteric modulator”. X-ray diffraction, 3 ligands (CLR, JTZ, M3J), 4 pockets (best druggability 0.79). MolNFT v1 #159002 on…

PDB
6OBA
Type
protein
Length
440 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-2 adrenergic RECEPTOR,LYSOZYME,BETA-2 adrenergic receptor
EC
3.2.1.17
UniProt
P07550, D9IEF7
Ligands
CLR, JTZ, M3J
Pockets
4 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 73% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-2 adrenergic RECEPTOR,LYSOZYME,BETA-2 adrenergic receptor (EC 3.2.1.17)protein44073% helix, 3% strandP07550, D9IEF7

Ligands and binding sites

  • CLR · Cholesterol · ligand · 2 copies · chains A
  • JTZ · (2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylphenoxy)propan-2-ol · ligand · chains A
  • M3J · 6-bromo-N~2~-phenylquinazoline-2,4-diamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13090.790.9042JTZ
22340.610.8125empty
31920.520.7828empty
41140.420.7615empty

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6OBA · The beta2 adrenergic receptor bound to a negative allosteric modulator · the same entry in another collection · chain A against A, TM-score 1.00
  • P07550 · AlphaFold monomer V2.0 prediction for beta-2 adrenergic receptor (P07550) · a predicted model of the same protein · chain A against A, TM-score 0.66

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.